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Although Rift Valley fever is a  natural disease of sheep with a  mor- 
tality of 50-95 per cent, it occurs also in man as an acute febrile illness, 
usually of such a  mild character that in over 200 cases known to have 
occurred  in  British  East  Africa no untoward  sequelae  were  observed 
(1).  The purpose  of the present  communication is  to report  a  case of 
laboratory infection--the  first known instance  of Rift Valley fever in 
America--which terminated  in death. 
Rift Valley fever or enzootic hepatitis  occurs among sheep in the Kenya Colony 
of British East Africa (1, 2).  Its symptoms are not striking; usually the  affected 
animals show little more than listlessness,  disinclination  to feed, and progressive 
weakness.  In older animals bloody diarrhea and thick  mucoid rhinitis may also 
be observed.  So rapid is  the course that many animals are found dead without 
ever having been  observed  to  be sick,  and in most  instances  death  supervenes 
within 24 hours after the initial sign of illness. 
At autopsy the chief pathological change found is an extensive necrosis of the 
liver.  In advanced cases,  the liver is affected to  such an extent that stained sec- 
tions of it are scarcely recognizable as hepatic  tissue.  The lobules consist merely 
of irregular shaped masses of broken-down, faintly staining cells intermingled with 
polymorphonuclear and mononuclear leucocytes; the Kupffer cells can no longer be 
distinguished.  In less advanced cases, the lobules of the liver are still  distinguish- 
able, but are studded with areas of necrosis of different sizes.  About the periphery 
of  these  foci  of degeneration  are  found  parenchymatous  cells  containing  cyto- 
plasmic hyaline bodies  similar  to  those described  originally by Councilman  (3) 
and more recently by Klotz and Belt (4) as occurring in the livers of human beings 
dead of yellow fever.  Acidophilic intranuclear inclusions are found in great num- 
ber,  which,  although usually of less  definite  outline and  not  so strongly acido- 
phllic,  resemble  those  associated with herpes  and Virus III.  In addition to the 
lesions in the liver, the ileum and large intestine  are often  the  seat of a  hemor- 
rhagic enteritis associated with congestion of the mesenteric and omental vessels. 
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Hemorrhages in other organs, especially in the cortex of lymphatic glands and 
beneath the capsules of the spleen and the kidneys, are also common. 
The etiological agent of Rift Valley fever has been shown by Daubney and 
Hudson (1) and others to be a filterable virus which invades the animal so com- 
pletely that it can be recovered from almost all organs of the body.  In addition 
to sheep, natural outbreaks have occurred among cattle and, as has been stated, 
spontaneous cases among human beings are common during the epizootics.  The 
disease has been produced experimentally in monkeys, goats, cats, rats, and in 
several species of mice.  Recovery  from the disease apparently confers a lasting 
immunity. 
Rift  Valley Fever in Man 
During the original investigations (1) of Rift Valley fever in Africa 
all four of  the  Europeans engaged in  the work  developed an  acute 
febrile illness characterized by general malaise, joint pains, and vague 
abdominal tenderness.  Blood taken from the workers at the height 
of their fever produced typical Rift Valley fever when injected into 
lambs.  Upon inquiry it was then learned that almost every native 
engaged in herding sheep during the epizootic had been sick for some 
days  and  had  complained  of  fever  accompanied  by  severe  pains 
throughout the body.  These illnesses were considered most probably 
to have been  attacks of Rift Valley fever.  A  native volunteer was 
then inoculated with the virus.  3 days after inoculation he developed 
headache and pains in the back, and, a day later, fever.  Blood taken 
from him at this  time  caused  Rift Valley fever when injected into 
lambs.  Following the investigations in Africa, the virus was sent to 
England for further study.  Soon after initiation of the work there, 
three laboratory workers developed the disease (2).  Up to the present 
time  the  attacks  in  the  eight  individuals mentioned represent  the 
only well observed cases of Rift Valley fever recorded in the literature. 
The following description of the disease is compiled from the  reports 
of these cases. 
The course of Rift Valley fever in man is much like that of a mild attack of 
influenza.  Following  an incubation period of 5 or 6 days, the patient complains 
of general malaise, chilly sensations, and headache.  After 6-12 hours of increasing 
symptoms the temperature, which has been normal, rises rapidly to 102-104°F. 
With the onset of fever, the patient may develop chills.  Pains  spread into the 
extremities and joints; a sensation of fulness over the region of the liver may be 
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sometimes occur, and in one instance epistaxis has been recorded.  On examination 
the patient is found to be moderately prostrated.  The face is flushed; conjunctival 
injection and photophobia may be present; the tongue is coated; the breath is foul. 
The lungs are normal, but there is definite tenderness in the epigastrium.  The 
liver and spleen cannot be felt.  Although fever and  symptoms may persist as 
long as 10 days or no longer than 1, improvement is usually evident about the 3rd 
day and proceeds rapidly to recovery.  In one case there was a second temperature 
reaction accompanied by a  return of symptoms 3  days after recovery from the 
initial attack.  At the onset of the symptoms there may be a slight polymorphonu- 
clear leucocytosis.  This gives way at about the time of appearance of fever to a 
leucopenia, the total white blood cell count reaching 3000-4000.  The fall in the 
number of leucocytes is almost entirely due to a  decrease in the number of the 
polymorphonuclear elements.  The  return  of  the  leucocyte count  to  a  normal 
level is slower than the clinical improvement.  Despite the period of probable liver 
damage in Rift Valley fever in man, the bile pigments of the blood serum and urine 
are usually not appreciably increased in amount. 
Report of Case 
A pathologist, R. S., age 30 years, had been working with Rift Valley fever virus 
for several weeks before the onset of his illness.  On the evening of December 22, 
1932, he felt chilly while walking home and complained that his eyes and the calves 
of his legs ached.  He found his subglossal temperature at that time to be 99.6°F. 
During the night his rest was disturbed by general malaise and pains, especially 
around the knees and hips.  On awakening, the 2nd day of illness, his temperature 
was 101°F.  He attempted to continue his work but had several chills during the 
day and felt so miserable that he took to bed.  He complained at this time of a 
vague soreness over his abdomen, constant dull headache, and pain behind the 
eyes  associated with  slight  photophobia.  There  was  no  sore  throat,  rhinitis, 
nausea, or vomiting.  He was admitted to the Hospital of The Rockefeller Insti- 
tute 24 hours after the onset of symptoms. 
On admission, the temperature was 102.6°F., pulse 140, respirations 24.  The 
patient  was  definitely  prostrated  by  his  illness but  rational  and  cooperative. 
There were found on physical examination a  slight injection of the throat, and a 
vague tenderness over the abdomen.  The edge of the liver was not felt.  Other 
than this the examination was entirely negative.  The  total leucocyte count at 
this time was 2800 per c. mm.  Polymorphonuclear elements constituted 57 per 
cent of this; small lymphocytes 9 per cent; intermediate lymphocytes 10 per cent; 
monocytes 24 per cent. I  The throat culture was negative for hemolytic strepto- 
cocci and influenza bacilli, and blood cultures in infusion broth remained sterile. 
The  urine  showed  a  faint  trace of albumin;  no  bile was present.  A  tentative 
diagnosis of Rift Valley fever or influenza was made. 
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In an attempt to confirm the tentative diagnosis of Rift Valley fever, 6 cc. of 
the patient's blood, drawn on the day of admission and kept fluid by the addition 
of 1 cc. of 1 : 1000 heparin solution, was injected intraperitoneally in 1 cc. amounts 
into six mice.  All of the mice died within 48 hours.  Their livers were free from 
ordinary bacteria, but showed in  hematoxylin-eosin-stained sections the marked 
focal necrosis and acidophilic intranuclear inclusions typical of Rift Valley fever. 
Moreover, the disease was transmitted to other mice by means of serial passages. 
Blood taken from the patient on the day following admission gave similar results. 
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CHART 1 
Consequently, the diagnosis of Rift Valley fever was confirmed.  In  Table I  and 
Chart  1 are shown the results of  these and subsequent tests for the presence of 
virus in the patient. 
Almost  immediately  after  admission  the  patient  began  to  improve.  The 
temperature,  which  reached  a  peak  of  103.8°F.  on  the night of admission, fell 
promptly to normal within 24 hours (Chart I).  The symptoms, however, abated 
somewhat less rapidly.  On the 5th day two papular areas several centimeters in 
diameter were observed on the right thigh and leg.  They resembled in a general 
way isolated measles papules.  After 3 days they had completely faded and since 
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any relation to the disease.  At the time of the appearance of the papules the 
patient developed a  sore throat.  The pharynx was irregularly injected and re- 
sembled the throats often seen in cases of influenza.  On the following day (6th 
day of illness) a typical herpes simplex eruption appeared on the right side of the 
nose.  Both this and the sore throat subsided in the next few days.  During all 
this time the patient had been improving generally, complaining for the most part 
only of a  constant  feeling of fulness in  the epigastrium which  he believed was 
aggravated by a persistent constipation.  There was a very slight and unexplained 
rise in temperature to a peak of 100.8°F. during the 10th day of illness. 
By the  12th day of illness the patient had improved to such an extent that he 
was allowed to sit in a chair for a short time and on the following day was permitted 
to walk a  short distance.  Thereafter, as his strength improved, his activity was 
increased.  On the evening of the 16th day, however, he complained of pain in 
TABLE  I 
Tests to Determine Presence of Virus in Patient 
Day of disease 
2 
3 
6 
8 
22 
45 (death) 
45 (death) 
Material tested 
Whole blood 
¢¢  ¢¢ 
¢¢  ¢c 
Sputum 
Liver 
Mesenteric lymph gland 
Mouse test 
6/6 
6/6 
O/6 
0/6 
0/2 
0/3 
0/3 
Result 
Positive 
gc 
Negative 
t¢ 
All material was injected intraperitoneally into mice. 
The denominator of the fractions signifies the total number of mice injected; 
the numerator denotes the number which died. 
the dorsal part of the left leg.  A diagnosis of phlebitis of the popliteal vein was 
made.  The patient was returned to bed and the leg was immobilized  in an elevated 
position.  4  days later (20th  day of illness) the patient awakened with pain in 
the right chest which was more pronounced during deep inspiration or exhalation. 
Although the physical and X-ray findings in the chest were entirely negative at 
this time, it became apparent as conditions progressed that the patient was suffer- 
ing from a  small pulmonary infarct.  Fever developed (103.4°F.); the leucocytes 
in the blood rose rapidly to 18,000 per c. ram. of which 94 per cent were granulo- 
cytes (Chart 1); dulness was apparent on percussion over the base of the right lung 
where the breath sounds, accompanied by many fine and coarse rMes, were dimin- 
ished.  In the X-ray photograph made at this time there was a  distinct shadow 
at  the base of the right lung.  On several occasions blood was expectorated in 
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virulent pneumococci mice were injected intraperitoneally with the sputum but all 
remained alive and well (Table I). 
During the following days the condition  in the chest improved gradually until 
the 26th day when the patient developed a second pulmonary infarct in the right 
lung (Chart 1).  Within a few days the patient began to improve again, but on the 
34th  day a  third  pulmonary infarct occurred,  this  time in  the left lung.  The 
temperature which  had just  returned  to normal, rose rapidly to  104.4°F.; the 
leucocytes reached 24,200 with 90 per cent granular elements.  By this time the 
patient had become very weak because of the repeated pulmonary insults.  In 
spite of this fact, however,  the temperature and leucocyte count again began a 
return to normal, and there was slow but progressive general improvement in the 
patient's condition.  On the 38th day of illness definite  signs of phlebitis in the 
right femoral vein developed.  This caused  no systemic reaction, however,  and 
recovery seemed to be proceeding uneventfully.  On the morning of the 45th day 
of illness, however, the patient suddenly collapsed and died within a few minutes. 
Death was apparently due to a large embolus in the pulmonary vessels. 
At autopsy, only changes directly associated with the phlebitis and pulmonary 
infarcts were found.  No abnormalities such as have been observed in animals 
dying of Rift Valley fever were seen.  This is not surprising,  however,  since the 
patient died 45 days after the onset of his illness of which the acute stage occupied 
only the initial week.  For this reason the pathological findings will be described 
but briefly.  There were signs of a mild saphenous and femoral phlebitis.  How- 
ever, in the inferior vena cava where it receives the hepatic veins, there was a large 
thrombus branching out into the hepatic venous radicles  and extending upward 
almost to the heart.  The superior portion of this thrombus had apparently be- 
come detached, and had travelled through the chambers of the heart because it was 
found as an embolus in the pulmonary artery.  In addition there were old pulmo- 
nary infarcts in both lungs with acute and chronic  pleuritis.  The liver appeared 
normal.  Examination  of  the  stained  sections  of  the  tissues  revealed  nothing 
unusual.  Emulsions made from bits of liver and from mesenteric lymph glands 
were injected intraperitoneally into mice in order to test for the presence of Rift 
Valley fever virus.  All the mice remained well (Table I). 
Tests for the Presence of Antibodies  in the Patient's Serum 
At intervals during the course of the disease, blood was drawn  from 
the patient in order to determine the  rapidity with which  antibodies 
to the virus are formed.  To this end serum was collected on the 6th, 
8th,  12th, and 15th days of illness and tested in the following manner. 
Decimal dilutions of infected mouse blood--ranging from 10-* to  10 -6 
--were prepared.  0.5 cc. amounts of each dilution of virus were added 
to 1.25 cc. amounts of each specimen of serum to be tested.  Without 
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each of two mice.  The mice were observed for 2 weeks to determine 
the mortality rate.  From the results shown in Table II it can be seen 
that antibodies were present in small amounts in the patient's blood as 
early as the  6th  day and  that  by the  12th  day had  reached  such  a 
concentration  that  protection was afforded the mice against  at  least 
1000 M.L.D. of the virus.  These findings are in agreement with  those 
of Findlay (2)  and Broom and Findlay (5). 
TABLE  II 
Test to Determine Presence of A ntibodies in Patient's Blood 
Sera 
Negative control 
Patient's serum 
Day o[ 
disease 
6 
8 
12 
15 
lO-S 
2/2 
2/2 
2/2 
0/2 
O/2 
Virus dilution 
10-4  10-5 
2/2  2/2 
2/2  2/2 
2/2  1/2 
o/2  o/2 
0/2  0/2 
10  4 
2/2 
1/2 
0/2 
0/2 
0/2 
Total 
8/8 
7/8 
5/8 
0/8 
o/8 
Mice 
protected 
tier Ce~ 
o 
12 
38 
lOO 
lOO 
The denominator  of the fractions signifies the  total number of mice injected; 
the numerator denotes the number which died. 
DISCUSSION 
For purposes of discussion, the course of disease in this case may be 
divided into two phases--the acute illness and the period of complica- 
tions.  Concerning the first or acute stage, little need be said because 
the  symptoms  and  signs  differed  in  no  essential  detail  from  those 
previously described as characteristic of Rift Valley fever in man.  In 
fact, with such a  typical syndrome, following definite exposure to the 
specific virus which in turn was isolated from the blood of the patient, 
there  can  be little  doubt  as  to  the  true  nature  of  the  illness.  The 
diagnosis is further strengthened by the demonstration in the patient's 
blood of specific virus-neutralizing  antibodies which during  the  early 
days of convalescence increased in amounts to reach a  concentration 
capable of neutralizing at least 1000 M.L.D. of the active agent. 
The phlebitis, however, which appeared during convalescence, came 
as an  unexpected complication.  The  condition  is not  mentioned  in 
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and Daubney has reported (6) that enquiries concerning its occurrence 
in the  Rift Valley have failed  to elicit any  affirmative information. 
However,  it is not  altogether  surprising  that  phlebitis  should occur 
during convalescence from Rift Valley fever, since it has been reported 
following almost all other known acute infectious diseases.  Its rela- 
tively high incidence in pneumonia--0.72 per cent (7)--and  in typhoid 
fever--2 per cent (8)--is well known.  In the diseases thought  to be 
due  to  filterable  viruses  it  also  occurs  but  less  frequently.  Thus, 
phlebitis has been reported following measles (9),  mumps (10), vari- 
cella (11), smallpox (12), vaccinia (13), influenza (14), and psittacosis 
(15).  What  factors predispose a  patient  to this  complication is not 
known, and no attempt will be made at this time to discuss the con- 
dition further than to point out its definite though infrequent occur- 
rence  in  association  with  most  acute  infectious  diseases.  It  seems 
probable that should the number of cases of Rift Valley fever increase, 
phlebitis will again be seen as a complication in a certain percentage of 
them. 
ST0-M_~ARY 
A case of Rift Valley fever following an accidental laboratory  infec- 
tion, and believed to be the first instance of the disease in the Western 
hemisphere, is reported.  Although the course of illness was otherwise 
quite  typical,  it  was  complicated by  thrombophlebitis--a  condition 
not  previously  described  in  association  with  this  disease  in  man. 
Death was caused by a pulmonary embolus. 
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